
Yemaachi Biotechnology
Yemaachi Biotechnology is a YC Summer 2021 (S21) company. Based in Accra, Greater Accra Region, Ghana. Team of 16.
About Yemaachi Biotechnology
Summary
Yemaachi Biotechnology collects and sequences cancer samples across Africa to build a clinical and molecular genomics knowledgebase on African populations, the most genetically diverse on earth. It uses that data to optimize existing precision diagnostic tests and help biopharma and diagnostics companies discover new ones, replacing the near-total absence of African genomic representation in oncology research and product development.
Go-to-market
Biopharma and diagnostics companies are the primary customers, engaging Yemaachi through research services and data partnerships to access African cancer genomics they cannot source elsewhere.
From the Y Combinator listing
Diversifying precision cancer diagnostics and treatments
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Facts
- Healthcare / Healthcare -> Diagnostics
- Accra, Greater Accra Region, Ghana
- 16
- Active
- Early
Founders (4)
- Joyce Ngoi
- Yaw Attua-Afari
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works